RBR-6789t4v招募中2 期
Amantadine for disorders of consciousness after Aneurysmal Subarachnoid Hemorrhage
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo0 个研究点开始时间: 2023年1月19日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 0 至 0（—）
入选标准
- •Patients with spontaneous subarachnoid hemorrhage due to cerebral aneurysm rupture; adults; both genders
排除标准
- •Unfavorable previous baseline neurological status, defined as modified Rankin Scale (mRS) greater than 2; pediatric patients
研究者
相似试验
招募中
2 期
Amantadin as adjuvant therapy in the treatment of moderate to severe OCDObsessive-compulsive disorderObsessive- Cumpulsive Disorder.IRCT201705191556N99Tehran University of Medical Sciences50
招募中
1 期
AmaNtadine for NeuroenhancEment in acutE patients Study - A prospective pilot proof of concept phase IIb study in intensive and intermediate care unit patients (ANNES)unresponsive wakefulness syndrome nototherwise explainedCTIS2024-512333-33-00niversitaetsklinikum Tuebingen AöR50
进行中（未招募）
1 期
AmaNtadine for NeuroenhancEment in acutE patients Study - A prospective pilot proof of concept phase IIb study in intensive and intermediate care unit patients (ANNES)EUCTR2022-002418-18-DEniversity Hospital Tübingen50
尚未招募
3 期
The effect of amantadine on the recovery of patients with traumatic brain injuryIRCT20190618043934N18Birjand University of Medical Sciences51
进行中（未招募）
1 期
The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virusEUCTR2021-001144-98-PLSamodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie200